According to XRF Scientific Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 30.305. At the end of 2023 the company had a P/E ratio of 19.5.
Year | P/E ratio | Change |
---|---|---|
2023 | 19.5 | 68.5% |
2022 | 11.6 | 14.03% |
2021 | 10.1 | 7.25% |
2020 | 9.46 | -5.22% |
2019 | 9.98 | -38.78% |
2018 | 16.3 | -24.57% |
2017 | 21.6 | 82.96% |
2016 | 11.8 | 38.59% |
2015 | 8.53 | 13.15% |
2014 | 7.54 | 6.85% |
2013 | 7.05 | 21.08% |
2012 | 5.83 | 13.58% |
2011 | 5.13 | -84.24% |
2010 | 32.5 | 668.86% |
2009 | 4.23 | -31.53% |
2008 | 6.18 | -75.13% |
2007 | 24.9 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.